Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P52742 (
pT3
)
1,034
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Leucine-rich repeat-containing G protein-coupled receptor 5(
LGR5
) was identified as the stem cell marker of colon cancer stem cells(CSCs),which were considered as the main criminal cells initiation and reinitiation of colon cancer. We intended to demonstrate and further explain the relationship between
LGR5
and colon cancer in mice model and patients. In our research, we used transcriptional methods and immunohistochemistry to investigate the
LGR5
gene and protein expression, examined proliferating cell nuclear antigen(PCNA) and Ki67 which were the classic markers for cell proliferation in
LGR5
protein positive and negative colon cancer among mice model and patients. Our results showed that
LGR5
mRNA and protein expression was significantly over-expressed in 193/366 patients and 24/40mice model with primary colon cancer contrasted with matched normal tissues; significantly higher
LGR5
gene expression was detected in pT4 cases than that in
pT3
cases; PCNA and Ki67 expression was much more increase in colon cancer cells with positive
LGR5
expression than those with negative
LGR5
expression;
LGR5
positive cancer not only in mice model but also in patients have shorter survival rate compared with
LGR5
negative cancer. All our study manifested that
LGR5
took on an important effect in the initiation and progression of colon cancer, provided also more helpful evidence for clinical diagnosis and an useful indicator for adjuvant therapy.
...
PMID:Over-expression of LGR5 correlates with poor survival of colon cancer in mice as well as in patients. 2406 90